The importance of herbal remedies in pharmacovigilance systems is becoming one of the primary tasks, due to the constantly ascending potential of herbal products and herbal medicines worldwide. Nowadays, the drug development is focused on finding new active compounds or combinations, but costs are simultaneously growing, which makes herbal medicines an attractive, harmless and cheaper alternative to synthetic drugs.
Like all drugs, herbal are not free of risk and many studies suggest for potential adverse reactions and interactions. Available statistics show that some herbal products, used in traditional medication for generations, may possess carcinogenic, hepatotoxic, cardiotoxic and other severe actions. Evaluation of the safety should include at least in vitro and in vivo genotoxicity assays, long-term rodent carcinogenicity tests (for drugs intended to be continuously used for >3 months or intermittently for >6 months), reproductive and developmental toxicity studies in some cases and examination of the effects on drug-metabolizing enzymes. Drug safety of herbal medicines should be developed, focusing on specific groups of patients.
Mann RD, Andrews EB. Pharmacovigilance, Chichester, John Wiley & Sons, Ltd. 2002
2.
“WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance systems”, World Health Organization, Geneva. 2004
3.
MosihuzzamanMChoudharyM I2008Protocols on safety, efficacy, standardization, and documentation of herbal medicine (IUPAC Technical Report)Pure Appl. Chem801021952230
4.
Bensoussan A, Myers SP. Towards a Safer Choice: The Practice of Traditional Chinese Medicine in Australia. Faculty of Health, University of Western Sydney, Macarthur. 1996
5.
AwodeleODanielAPopoolaTDSalamiEF2013A study on pharmacovigilance of herbal medicines in Lagos West Senatorial District, NigeriaInt J Risk Saf Med254205217
BaileyJJGahcheJJLentinoCVDwyerJTEngelJSThomasRTBetzJMSemposCTPiccianoMF2011Dietary supplement use in the United States, -J Nutr1412261266
9.
LeeRBalickMJ2001Ethnomedicine: Ancient Wisdom for Contemporary HealingAlternative Therapies in Health and Medicine732830
10.
CuzzolinLBenoniG2009Herbal Drugs: Ethnomedicine to Modern Medicine. Chapter 21: Safety Issues of Phytomedicines in Pregnancy and PaediatricSpringer Berlin HeidelbergHeidelberg21381396
Doughari JH. Phytochemicals - A Global Perspective of Their Role in Nutrition and Health, Chapter 1: Phytochemicals: Extraction Methods, Basic Structures and Mode of Action as Potential Chemotherapeutic Agents. 2012
13.
Cragg GM, Newman DJ. Plants as a Source of Anti-Cancer Agents. In: Elisabetsky E, Etkin NL (eds). Encyclopedia of Life Support Systems (EOLSS): Ethnopharmacology, Vol. 1, Developed under the Auspices of the UNESCO, EOLSS Publishers, Oxford, Reino Unido. 2006; 183–97
14.
Food and Drug Administration Centre for Drug Evaluation and Research (CDER). Guidance for Industry, Botanical Drug Products. U.S. Department of Health and Human Services. 2004
15.
Kamboj A. Drug Discovery Research in Pharmacognosy. Chapter 3, Analytical Evaluation of Herbal Drugs - ed. by Vallisuta O, Olimat SM, 2012
16.
WHO Guideline on good agricultural and collection practices, World Health Organization, Geneva. 2003
17.
Agricultural and Collection Practice for starting materials of Herbal Origin in European Union EMEA/HMPC/246816/05, The European Medicines Agency. 2005
18.
Agricultural and Collection Practice for starting materials of Herbal Origin in European Union EMEA/HMPC/246816/05, The European Medicines Agency. 2005
19.
WHOguidelines on good manufacturing practices (GMP) for herbal medicines.World Health Organization, Geneva. 2007
20.
Directive 2004/24/EC of the European Parliament and of the Council. The European Medicines Agency.2004
21.
Resolution WHA23.13 on international monitoring of adverse reactions to drugs. 1970
22.
Directive 2001/83/EC of the European Parliament and of the council of 6 November 2001 on the Community code relating to medicinal products for human use. The European Medicines Agency. 2011
23.
Guideline on the use of the CTD format in the preparation of a registration application for traditional herbal medicinal products, EMA/HMPC/71049/2007 Rev. 1, The European Medicines Agency. 2007
24.
Guideline on non-clinical documentation for herbal medicinal products in applications for marketing authorisation (bibliographical and mixed applications) and in applications for simplified registration (EMEA/HMPC/32116/2005). The European Medicines Agency. 2005
25.
2011National Toxicology Program-Toxicology and carcinogenesis studies of pulegone (CAS No. 89-82-7) in F344/N rats and B6C3F1 mice (gavage studies)Natl Toxicol Program Tech Rep Ser5631201
26.
MehtaUC2011Pharmacovigilance: The devastating consequences of not thinking about adverse drug reactions, CME: Continuing Medical Education296247
27.
WHO Drug Dictionary. Uppsala Monitoring Centre electronic database, updated quarterly. Available from: http//www.umcproducts.com/
28.
BaldwinCA1987What pharmacists should know about feverfewPharm J239237238
ChanALLeungHWWuJWChienTW2011Risk of hemorrhage associated with co-prescriptions for Ginkgo biloba and antiplatelet or anticoagulant drugsJ Altern Complement Med176513517
31.
ChenCHDickmanKGHuangCYMoriyaMShunCTTaiHCHuangKHWangSMLeeYJGrollmanAPPuYS2013Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: Clinical characteristics and outcomesInt J Cancer13311420
32.
MeiNGuoLFuPPFuscoeJCLuanYChenT2010Metabolism, genotoxicity, and carcinogenicity of comfrey. Absence of mutagenic effects of a particularJ Toxicol Environ Health B Crit Rev137-8509526
33.
GoldsteinLHEliasMRon-AvrahamG2007Consumption of herbal remedies and dietarysupplements amongst patients hospitalized in medical wardsBr J Clin Pharmacol64373380
34.
AndersenMRSweetEZhouMStandishLJComplementary and Alternative Medicine Use by Breast Cancer Patients at Time of Surgery Which Increases the Potential for Excessive BleedingIntegr Cancer Ther[Epub ahead of print] pii: 1534735414555808
35.
LeeVGoyalAHsuCCJacobsonJSRodriguezRDSiegelAB2014Dietary Supplement Use Among Patients With Hepatocellular CarcinomaIntegr Cancer Ther[Epub ahead of print]. pii: 1534735414550038
36.
DamerySGratusCGrieveRWarmingtonSJonesJRoutledgePGreenfieldSDowswellGSherriffJWilsonS2011The use of herbal medicines by people with cancer: A cross-sectional surveyBr J Cancer1046927933
37.
GratusCWilsonSGreenfieldSMDamerySWarmingtonSGrieveRStevenNMRoutledgeP2009The use of herbal medicines by people with cancer: A qualitative studyBMC Complement Altern Med914
38.
JinYLiuZChenXWangXWangDJiangZLiuYWangJZouWGuoHXuL2014Survival of people living with HIV after treatment with traditional Chinese medicine in Henan province of China: A retrospective cohort studyTradit Chin Med344430436
39.
ZhaoHJSunCZJiangWPDaiZKShiWXYangKKMuXJZhangXXSuiY2014Eight-year survival of AIDS patients treated with Chinese herbal medicineAJCM422261274
40.
OnifadeAAAjeigbeKOOmotoshoIORahamonSKOladeindeBH2013Attitude of HIV patients to herbal remedy for HIV infection in NigeriaNiger J Physiol Sci281109112
41.
OlorunnisolaOSAdetutuABalogunEAAfolayanAJ2013Ethnobotanical survey of medicinal plants used in the treatment of malaria in Ogbomoso, Southwest NigeriaJ Ethnopharmacol15017178
42.
TraoreMSBaldéMADialloMSBaldéESDianéSCamaraADialloABaldeAKeïtaAKeitaSMOularéKMagassoubaFBDiakitéIDialloAPietersLBaldéAM2013Ethnobotanical survey on medicinal plants used by Guinean traditional healers in the treatment of malariaJ Ethnopharmacol12150(3)11451153
43.
MesiaKTonaLMampunzaMMNtamabyaliroNMuandaTMuyembeTMusuambaTMetsTCimangaKTottéJPietersLVlietinckAJ2012Antimalarial efficacy of a quantified extract of Naucleapobeguinii stem bark in human adult volunteers with diagnosed uncomplicated falciparum malaria. Part 2: A clinical phase IIB trialPlanta Med789853860
44.
VinsonJABurnhamBRNagendranMV2012Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjectsDiabetes Metab Syndr Obes52127
45.
Revuelta-IniestaRAl-DujailiEA2014Consumption of green coffee reduces blood pressure and body composition by influencing 11β-HSD1 enzyme activity in healthy individuals: A pilot crossover study using green and black coffeeBiomed Res Int482704
46.
KhazanMHedayatiMKobarfardFAskariSAziziF2014Identification and determination of synthetic pharmaceuticals as adulterants in eight common herbal weight loss supplementsIran Red Crescent Med J163
47.
HarroldJAHughesGMO’ShielKQuinnEBoylandEJWilliamsNJHalfordJC2013Acute effects of a herb extract formulation and inulin fibre on appetite, energy intake and food choiceAppetite628490
48.
GlauserTATitanic-SchefftMPippengerCE1999Racial differences in free radical scavenging enzyme activity in childrenChild Neurol146382387
49.
ChenML2006Ethnic or racial differences revisited: Impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamicsClin Pharmacokinet4510957964
50.
ArcuryTASuerkenCKGrzywaczJGBellRALangWQuandtSA2006Complementary and alternative medicine use among older adults: Ethnic variationEthn Dis16723731
51.
YakubuMTMusaIF2012Effects of Post-coital Administration of Alkaloids from Senna alata (Linn. Roxb) Leaves on some Fetal and Maternal Outcomes of Pregnant RatsJ Reprod Infertil134211217
